(Q47763163)

5 February 2018

title

Fatty acids as determinants of in-vivo lipid peroxidation: the EFFGE study in Eastern Finnish hypertensive and non-hypertensive subjects (English)

1 reference

5 February 2018

0 references

Jari E Kaikkonen

1

1 reference

5 February 2018

Teemu Vilppo

2

1 reference

5 February 2018

Janne Asikainen

3

1 reference

5 February 2018

Sari Voutilainen

4

1 reference

5 February 2018

Sudhir Kurl

5

1 reference

5 February 2018

Jukka T Salonen

6

1 reference

5 February 2018

language of work or name

English

0 references

publication date

3 July 2013

1 reference

5 February 2018

published in

Annals of Medicine

1 reference

5 February 2018

volume

45

1 reference

5 February 2018

issue

5-6

1 reference

5 February 2018

page(s)

455-464

1 reference

5 February 2018

Oxidation of LDL and its clinical implication

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Generation and biological activities of oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on E

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Prostanoid and isoprostanoid pathways in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Recent advances in the biochemistry and clinical relevance of the isoprostane pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

HDL is the major lipoprotein carrier of plasma F2-isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

HDL, lipid peroxidation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Factors associated with oxidative stress in human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Old study sheds new light on the fatty acids and cardiovascular health debate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

F2-isoprostanes as an indicator and risk factor for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Clinical cardiovascular studies of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Exhaustive exercise increases plasma/serum total oxidation resistance in moderately trained men and women, whereas their VLDL + LDL lipoprotein fraction is more susceptible to oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Systematic review on the association between F2-isoprostanes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

Chemistry and biochemistry of lipid peroxidation products.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2013.809915

10.3109/07853890.2013.809915

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018